154 related articles for article (PubMed ID: 36123923)
1. Treatment of membranous nephropathy with crescent nephritis by rituximab: A case report.
Zhang F; Yang Y; Chen Y; Chen Y; Yin W; Liang Y; Luo X
Medicine (Baltimore); 2022 Sep; 101(37):e30663. PubMed ID: 36123923
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: A case report.
Lu H; Cui Z; Zhou XJ; Jin QZ; Yu XJ; Wang SX; Wang Y; Zhou FD; Zhao MH
Medicine (Baltimore); 2019 May; 98(18):e15303. PubMed ID: 31045764
[TBL] [Abstract][Full Text] [Related]
3. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
[TBL] [Abstract][Full Text] [Related]
4. Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.
Ruggenenti P; Debiec H; Ruggiero B; Chianca A; Pellé T; Gaspari F; Suardi F; Gagliardini E; Orisio S; Benigni A; Ronco P; Remuzzi G
J Am Soc Nephrol; 2015 Oct; 26(10):2545-58. PubMed ID: 25804280
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
Ishiwatari A; Wakai S; Shirakawa H; Honda K
Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
[TBL] [Abstract][Full Text] [Related]
6. Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature.
Meyer N; Cooper W; Kirwan P; Garsia R; Dunkley S; Gracey DM
BMC Nephrol; 2021 Jul; 22(1):268. PubMed ID: 34294065
[TBL] [Abstract][Full Text] [Related]
7. [Membranous nephropathy: New insights in therapeutic approach].
Dahan K
Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
[TBL] [Abstract][Full Text] [Related]
8. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
[TBL] [Abstract][Full Text] [Related]
9. A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up.
Zhou XJ; Zhou FD; Wang SX; Zhao MH
Medicine (Baltimore); 2018 Jun; 97(25):e11184. PubMed ID: 29924035
[TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab.
Dedinská I; Svetlík D; Adamicova K; Machalekova K; Makovicky P; Jezikova A; Laca L; Miklusica J; Galajda P; Mokan M
Iran J Kidney Dis; 2016 Sep; 10(5):332-335. PubMed ID: 27721233
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function.
Ogawara A; Harada M; Ichikawa T; Fujii K; Ehara T; Kobayashi M
Tohoku J Exp Med; 2017 Dec; 243(4):335-341. PubMed ID: 29269610
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.
Wang J; Zhu P; Cui Z; Qu Z; Zhang YM; Wang F; Wang X; Wang JW; Zhu SN; Liu G; Zhou FD; Zhao MH
Medicine (Baltimore); 2015 Dec; 94(50):e2294. PubMed ID: 26683965
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of long-term repeated rituximab treatment in refractory phospholipase A2 receptor-antibody-related membranous nephropathy.
Zhang L; Chen M; Le W; Zhang M; Tu Y; Zuo K; Chen D; Wu Y; Li S; Zeng C; Cheng Z; Xie H
Immunotherapy; 2022 Oct; 14(15):1237-1244. PubMed ID: 36097696
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
16. Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab.
Yoshida S; Hanai S; Nakagomi D; Kobayashi K; Takahashi K; Furuya F
Intern Med; 2021 Jan; 60(1):145-150. PubMed ID: 32830174
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease.
Jindal N; Yadav D; Passero C; Krasinskas A; Craig F; Bastacky S; Liang KV
Clin Nephrol; 2012 Apr; 77(4):321-8. PubMed ID: 22445476
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
[TBL] [Abstract][Full Text] [Related]
19. Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial.
Scolari F; Dallera N; Gesualdo L; Santoro D; Pani A; Santostefano M; Feriozzi S; Mani LY; Boscutti G; Messa P; Magistroni R; Quaglia M; Ponticelli C; Ravani P
BMJ Open; 2019 Dec; 9(12):e029232. PubMed ID: 31806605
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]